SCHEMBL14812759

SCHEMBL14812759

O=c1[c]nc(N2CCCC2)c[nH]1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IP6K1 Q92551 2/20 0.36
MAPT P10636 2/20 0.36
KDM4C Q9H3R0 1/20 0.36
CASP1 P29466 1/20 0.33
CASP4 P49662 1/20 0.33
CASP5 P51878 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
ELANE P08246 2/20 0.32
EGLN2 Q96KS0 1/20 0.32
POLB P06746 2/20 0.31
ALDH1A1 P00352 3/20 0.31
LMNA P02545 1/20 0.31
HSP90AA1 P07900 1/20 0.31
CCR6 P51684 1/20 0.31
CACNA1B Q00975 1/20 0.31
APBA1 Q02410 1/20 0.31
APOBEC3G Q9HC16 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CYP1A2 P05177 1/20 0.31
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL564259 0.68 CASP1 (0.37) IP6K1MAPTCASP1CASP4CASP5
SCHEMBL660176 0.67 CYP1A2 (0.37) MAPTCASP1CASP4CASP5HRH4
SCHEMBL6986620 0.63 CRHBP (0.46) MAPTCASP1CASP4CASP5HRH4
SCHEMBL8540547 0.63 CYP1A2 (0.46) MAPTCASP1CASP4CASP5POLB
SCHEMBL18668207 0.62 CYP1A2 (0.48) MAPTPOLBALDH1A1LMNATDP1
SCHEMBL6500066 0.60 JAK3 (0.41) IP6K1MAPTCASP1CASP4CASP5
SCHEMBL4019264 0.60 CASP1 (0.45) MAPTCASP1CASP4CASP5HRH4
SCHEMBL3598725 0.60 MAPT (0.41) MAPTPOLBALDH1A1LMNATDP1
SCHEMBL4638253 0.57 HRH1 (0.35) MAPTCASP1CASP4CASP5ALDH1A1
SCHEMBL935607 0.57 CYP1A2 (0.39) MAPTCASP1CASP4CASP5HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2758398-B1 SUBSTITUTED N- [1-CYANO-2- (PHENYL) ETHYL]-2-AZABICYCLO [2.2.1]HEPTANE-3-CARBOXAMIDE INHIBITORS OF CATHEPSIN C BOEHRINGER INGELHEIM INT (DE) 2017-08-02 EP disclosed
US-8999975-B2 Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-04-07 US disclosed
EP-2758398-A1 SUBSTITUTED N- [1-CYANO-2- (PHENYL) ETHYL]-2-AZABICYCLO [2.2.1]HEPTANE-3-CARBOXAMIDE INHIBITORS OF CATHEPSIN C Boehringer Ingelheim International GmbH (DE) 2014-07-30 EP disclosed
US-20130172327-A1 SUBSTITUTED N- [1-CYANO-2- (PHENYL) ETHYL] -2-AZABICYCLO [2.2.1] HEPTANE-3-CARBOXAMIDE INHIBITORS OF CATHEPSIN C BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-07-04 US disclosed
WO-2013041497-A1 SUBSTITUTED N- [1-CYANO-2- (PHENYL) ETHYL] -2-AZABICYCLO [2.2.1] HEPTANE-3-CARBOXAMIDE INHIBITORS OF CATHEPSIN C BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-03-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130172327-A1 SUBSTITUTED N- [1-CYANO-2- (PHENYL) ETHYL] -2-AZABICYCLO [2.2.1] HEPTANE-3-CARBOXAMIDE INHIBITORS OF CATHEPSIN C CTSS, CTSB, CTSG IP6K1 4275/4885MAPT 4541/4885KDM4C 1693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.